| Lipids Management |
1 |
1 |
| Statins |
0 |
0.94 |
| Cardiovascular Risk Management |
0 |
0.4 |
| Hypertension |
0 |
0.35 |
| Coronary Artery Disease (CAD) |
0 |
0.31 |
| Cardiovascular disease |
0 |
0.19 |
| Heart |
0 |
0.19 |
| Type 2 Diabetes Mellitus |
0 |
0.99 |
| Cerebrovascular Accident |
0 |
0.14 |
| Acute Coronary Syndrome |
0 |
0.11 |
| Biliary Disease |
0 |
0.11 |
| Myalgia |
0 |
0.11 |
| Familial Hypercholesterolemia |
0 |
0.09 |
| Myocardial Infarction (MI) |
0 |
0.08 |
| Pain Management |
0 |
0.08 |
| Adverse Effects |
0 |
0.06 |
| Atherosclerosis |
0 |
0.06 |
| C-Reactive Protein (CRP) |
0 |
0.06 |
| Gallstone |
0 |
0.06 |
| Hypercholesterolemia |
0 |
0.06 |
| Infarction |
0 |
0.06 |
| LDL Cholesterol |
0 |
0.06 |
| Muscle |
0 |
0.06 |
| Ohio |
0 |
0.06 |
| Pain |
0 |
0.06 |
| Stress |
0 |
0.06 |